J-G Wang1, Z-J Zhong, Y-F Mo, L-C Wang, R Chen. 1. Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. 354713144@qq.com.
Abstract
OBJECTIVE: Many studies have been published recently on the characteristics of the clinical manifestations of COVID-19 in children. The quality scores of literature are different, and the incidence of clinical manifestations and laboratory tests results vary greatly. Therefore, a systematic retrospective meta-analysis is needed to determine the incidence of the clinical manifestations of COVID-19 in children. MATERIALS AND METHODS: Data from databases, such as PubMed, Web of science, EMBASE, Johns Hopkins University, and Chinese databases were analysed from January 31, 2020 to October 20, 2020. High-quality articles were selected for analysis based on a quality standard score. A meta-analysis of random effects was used to determine the prevalence of comorbidities and subgroup meta-analysis to examine the changes in the estimated prevalence in different subgroups. RESULTS: Seventy-one articles involving 11,671 children were included in the study. The incidence of fever, respiratory symptoms, gastrointestinal symptoms, asymptomatic patients, nervous system symptoms, and chest tightness was 55.8%, 56.8%, 14.4%, 21.1%, 6.7%, and 6.1%, respectively. The incidence of multisystem inflammatory syndrome was 6.2%. Laboratory examination results showed that lymphocytes decreased in 12% and leukocytes decreased in 8.8% of patients, whereas white blood cells increased in 7.8% of patients. Imaging showed abnormalities in 66.5%, and ground-glass opacities were observed in 36.9% patients. Epidemiological history was present in 85.2% cases; severe disease rate was 3.33%. The mortality rate was 0.28%. CONCLUSIONS: The clinical symptoms of COVID-19 in children are mild, and laboratory indicators and imaging manifestations are atypical. While screening children for COVID-19, in addition to assessing patients for symptoms as the first step of screening, the epidemiological history of patients should be obtained.
OBJECTIVE: Many studies have been published recently on the characteristics of the clinical manifestations of COVID-19 in children. The quality scores of literature are different, and the incidence of clinical manifestations and laboratory tests results vary greatly. Therefore, a systematic retrospective meta-analysis is needed to determine the incidence of the clinical manifestations of COVID-19 in children. MATERIALS AND METHODS: Data from databases, such as PubMed, Web of science, EMBASE, Johns Hopkins University, and Chinese databases were analysed from January 31, 2020 to October 20, 2020. High-quality articles were selected for analysis based on a quality standard score. A meta-analysis of random effects was used to determine the prevalence of comorbidities and subgroup meta-analysis to examine the changes in the estimated prevalence in different subgroups. RESULTS: Seventy-one articles involving 11,671 children were included in the study. The incidence of fever, respiratory symptoms, gastrointestinal symptoms, asymptomatic patients, nervous system symptoms, and chest tightness was 55.8%, 56.8%, 14.4%, 21.1%, 6.7%, and 6.1%, respectively. The incidence of multisystem inflammatory syndrome was 6.2%. Laboratory examination results showed that lymphocytes decreased in 12% and leukocytes decreased in 8.8% of patients, whereas white blood cells increased in 7.8% of patients. Imaging showed abnormalities in 66.5%, and ground-glass opacities were observed in 36.9% patients. Epidemiological history was present in 85.2% cases; severe disease rate was 3.33%. The mortality rate was 0.28%. CONCLUSIONS: The clinical symptoms of COVID-19 in children are mild, and laboratory indicators and imaging manifestations are atypical. While screening children for COVID-19, in addition to assessing patients for symptoms as the first step of screening, the epidemiological history of patients should be obtained.
Authors: Márcia Borges Machado; Thamirys Cosmo Grillo Fajardo; Lourival Benedito de Oliveira; Antonio Carlos de Quadros Junior; Daniel Thome Catalan; Karim Cristina Piovesan; Maria Emília De Domenico Garcia; Maurício Feliciano da Silva; Rita de Cássia de Aguirre Bernardes Dezena; Saulo Duarte Passos Journal: Int J Microbiol Date: 2022-07-05
Authors: Sebastian Gonzalez-Dambrauskas; Pablo Vasquez-Hoyos; Anna Camporesi; Edwin Mauricio Cantillano; Samantha Dallefeld; Jesus Dominguez-Rojas; Conall Francoeur; Anar Gurbanov; Liliana Mazzillo-Vega; Steven L Shein; Adriana Yock-Corrales; Todd Karsies Journal: Lancet Reg Health Am Date: 2022-05-17
Authors: Simone Cesaro; Per Ljungman; Malgorzata Mikulska; Hans H Hirsch; Marie von Lilienfeld-Toal; Catherine Cordonnier; Sylvain Meylan; Varun Mehra; Jan Styczynski; Francesco Marchesi; Caroline Besson; Fausto Baldanti; Raul Cordoba Masculano; Gernot Beutel; Herman Einsele; Elie Azoulay; Johan Maertens; Rafael de la Camara; Livio Pagano Journal: Leukemia Date: 2022-04-29 Impact factor: 12.883
Authors: Leihong Wu; Syed Ali; Heather Ali; Tyrone Brock; Joshua Xu; Weida Tong Journal: Int J Environ Res Public Health Date: 2022-08-12 Impact factor: 4.614